·On Sept. 22, the U.S. Food and Drug Administration (FDA) approved Lonsurf (a pill that combines two drugs, trifluridine and tipiracil) for patients with advanced colorectal cancer who…
Reader Survey
Please share your feedback! We’re interested to learn more about your experience with American Nurse Journal.